Hip Arthroscopy Market Size, Share and Trends Analysis | Global | 2023-2029 | MedCore | Includes: Radiofrequency Probes, Banana Blades, and 3 more

In 2022, the global hip arthroscopy market had a value of $367.2 million. It is projected to grow at a CAGR of 6.8% during the forecast period, ultimately reaching $580.9 million. The complete range of products available in the global market for hip arthroscopy comprises radiofrequency probes, banana blades, hip access kits, suture anchors, and disposable kits.

MARKET REPORT DATA TYPES INCLUDED:

• Unit Sales, Average Selling Prices, Market Value & Growth Trends

• Forecasts Until 2029, and Historical Data to 2019

• Market Drivers & Limiters for Each Segment

• Competitive Analysis with Market Shares for Each Segment

• Recent Mergers & Acquisitions

• Procedure Volumes

• Company Profiles, Product Portfolios and SWOT for Top Competitors

• COVID-19 Impact Analysis

PROCEDURE NUMBERS

Hip arthroscopy, along with shoulder labrum repair, is expected to be one of the rapidly growing segments of the overall orthopedic soft tissue repair and reconstruction procedures, with a robust single-digit CAGR. The increasing adoption and advancement of surgical techniques and instruments will be driven by the unsatisfied demand for the treatment.

GLOBAL HIP ARTHROSCOPY MARKET TRENDS

Due to its status as a relatively new and fast-growing field, hip arthroscopy currently faces a shortage of training and guidance. As interest in this area increases, there is a need for a dependable infrastructure of fellowship programs and training, accompanied by long-term clinical outcomes. With the ongoing development of the technique, there is a rising trend towards sports medicine fellowship programs that offer more comprehensive and advanced training in this field.

GLOBAL HIP ARTHROSCOPY MARKET SHARE INSIGHTS

The global hip arthroscopy market is primarily dominated by three major competitors, namely Arthrex, Stryker, and Smith & Nephew. In 2022, Arthrex held the top position as the leading competitor in the hip arthroscopy market. Arthrex has established its presence in the suture anchor market with its PushLock® and SutureTak® product lines. Additionally, Arthrex provides CoolCut™ Radio Frequency Ablation and NAV-X® Steerable Ablators as radiofrequency probe options.

GLOBAL HIP ARTHROSCOPY MARKET SEGMENTATION SUMMARY

• Radiofrequency Probe Market
• Banana Blade Market
• Hip Access Kits
• Suture Anchors
• Disposable Kits

RESEARCH SCOPE SUMMARY

• Regions: North America (Canada, United States), Latin America (Argentina, Brazil, Chile, Colombia, Mexico, Peru, Venezuela), Western Europe (Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, U.K.), Central & Eastern Europe (Baltic States, Bulgaria, Croatia, Czech Republic, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Turkey, Ukraine), Middle East (Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates), Asia Pacific (Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Malaysia, Myanmar, New Zealand, Philippines, Singapore, South Korea, Taiwan, Thailand, Vietnam), Africa (Algeria, Egypt, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda)

• Base Year: 2022
• Forecast Period: 2023-2029
• Historical Data: 2019-2022

• Quantitative Data: Market Size, Market Share, Market Growth Rates, Units Sold, Average Selling Prices

• Qualitative Data: COVID-19 Impact, Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios

• Data Sources: Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data.

Read more about iData's 9-Step Research Methodology.

WHY CHOOSE IDATA?

• Experts Only - iData has been around for over 17 years and is the trusted source of intelligence, and data-driven insights for key industry players. We are made up of specialists with a sole focus on medical devices, dental devices and pharmaceuticals. Our research and consulting field of endeavour never strays from the medical device industry and, because of this, we are the number one choice for leading companies in this field.

• Global Coverage - iData's unique methodology, and its expansion to over 70 countries world-wide, has made it one of the most viable sources of intelligence for global companies along with those who plan to expand their portfolio beyond the confines of their own country. Providing procedural data at the country level is another testimony to the trusted global coverage we provide.

• Attention to Detail - It's our attention to small details, scheduling of timelines, and keen project management that makes us stand out from the rest. We are creative, and our reports include metrics such as procedure numbers, ASPs, and SKU-level insights that are not found elsewhere.

• Pricing - When comparing like-with-like, iData's prices are not only extremely competitive but also the most cost-effective. We strive for success and want the same for our clients. With the level of detail incorporated into each report alongside the extensive segmentation provided, no other report compares at our price point.